News | October 28, 2013

Promedica Toledo Hospital Offers Innovative Tool for Detecting Breast Cancer

Toledo Hospital is the first hospital in Ohio to offer VolparaDensity, a breast screening tool used to calculate breast density

mammography systems women's health volpara volpara density promedica
October 28, 2013 — Radiologists at ProMedica Toledo Hospital Breast Care Center have a new tool to help evaluate breast tissue density on a mammogram. The U.S. Food and Drug Administration (FDA)-cleared VolparaDensity is a breast imaging software tool that uses complex physics and software to measure the amount of tissue within a patient’s breast. This information is used by a breast imaging radiologist to decide if additional breast screening beyond a mammogram might be necessary.
Toledo Hospital is the first hospital in Ohio to offer VolparaDensity. Robin Shermis, M.D., medical director, Toledo Hospital Breast Care Center, said the center selected VolparaDensity because it offers a consistent and standardized approach to calculating breast density when used in conjunction with the radiologist.
“We evaluated other commercially available density measurement tools, but adopted VolparaDensity because it has been proven to offer a reliable and objective volumetric measurement,” said Shermis. “Our patients can take comfort in knowing that when they come to our center, they will be thoroughly assessed and vectored to additional screening in our effort to improve the early detection of cancer.”
For more information:

Related Content

Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow
News | Women's Health | August 01, 2017
Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
Radiotherapy Prior to Surgery Reduces Secondary Tumor Risk in Early-Stage Breast Cancer Patients
News | Radiation Therapy | July 24, 2017
Moffitt Cancer Center researchers launched a first-of-its-kind study comparing the long-term benefits of radiation...
Kubtec Launches New Website For Digital Imaging and Irradiation Products
News | Digital Radiography (DR) | July 20, 2017
Kubtec announced the launch a new website focused on the applications of digital X-ray imaging and irradiation for...
Volpara Solutions to Showcase Volpara Enterprise DDP Software at AHRA 2017
News | Mammography | July 11, 2017
Volpara Solutions Inc. will showcase its new Volpara Enterprise DDP software at the Association for Medical Imaging...
Fujifilm Showcases Digital Radiography, Mammography Innovations at AHRA 2017
News | Digital Radiography (DR) | July 06, 2017
Fujifilm Medical Systems U.S.A. Inc. will present its comprehensive portfolio of digital radiography (DR) and...
Feature | Breast Density | July 05, 2017 | By Nancy M. Cappello, Ph.D.
Two decades of research on the masking risk of dense breast tissue by mammography screening is indisputable. As the...
Solis Mammography Ranks No. 19 in Dallas Business Journal’s Middle Market 50
News | Mammography | June 30, 2017
June 30, 2017 — Solis Mammography was named the 19th fastest-growing, middle-market company in North Texas by the
GE Healthcare Announces First U.S. Installation of Senographe Pristina Mammography System
News | Mammography | June 29, 2017
GE Healthcare has collaborated with Boca Raton Regional Hospital (Boca Raton, Fla.) to bring a more comfortable...
Overlay Init